Selected Grants
Skeletal muscle-targeted gene therapy for Pompe disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Off-target effect analysis for genome editing in GSD Ia
ResearchCo Investigator · Awarded by North Carolina Biotechnology Center · 2026 - 2027Dissecting AAV silencing in humanized mice
ResearchInvestigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2023 - 2027Understanding de-targeting mutation sand AAVR interactions
ResearchCo Investigator · Awarded by Asklepios BioPharmaceutical, Inc. · 2025 - 2026Human Metabolome Related to PFAS Exposure
ResearchCo Investigator · Awarded by NC Department of Environmental Quality · 2024 - 2026Validation of next generation humanized mouse models
ResearchInvestigator · Awarded by AvaChrome · 2022 - 2026Transplant liver screening for xenograft models of lipid disorders
ResearchCo Investigator · Awarded by Spark Therapeutics, Inc. · 2024 - 2025Mechanisms of Liver Toxicity of Anti-Depressant Duloxetine
ResearchCo Investigator · Awarded by Baylor College of Medicine · 2023 - 2024Research Collaboration, Icagen and Duke University
ResearchVeterinary Pathologist · Awarded by Icagen, Inc · 2022 - 2024Physiological Dissection of the Mevalonate Pathway
ResearchInvestigator · Awarded by Baylor College of Medicine · 2020 - 2024Epigenetic Modulation of Therapeutic Targets in FRG Mice
ResearchInvestigator · Awarded by Tune Therapeutics · 2022 - 2023Therapeutic pathway reprogramming for metabolic liver disease
ResearchInvestigator · Awarded by National Institutes of Health · 2018 - 2022Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse
ResearchInvestigator · Awarded by National Institutes of Health · 2020 - 2022External Relationships
- Avachrome Inc.
- HHS/NIH
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.